고형암 (전체) | 바이오모아

CGTBiologicstaleTILT Biotherapeutics Ltd.Phase 2

TILT-123 (TILT-123)

Melanoma; Head and Neck Squamous Cell Carcinoma · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 6상태 RECRUITING

CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 2

4SCAR-GD2 (4SCAR-GD2)

Solid Tumor · GD2

#GD2#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 5상태 RECRUITING

CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

AFP Specific T Cell Receptor T Cells (AFP Specific T Cell Receptor T Cells)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 5상태 RECRUITING

AntibodystaleAravive, Inc.Phase 2

Batiraxcept (Batiraxcept)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2

효능 ORR 11%임상시험 5상태 DISCONTINUED

AntibodystaleMerck Sharp & Dohme LLCPhase 2

Boserolimab (Boserolimab)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+4

효능 ORR 7.1%임상시험 5상태 RECRUITING

CGTBiologicstaleGuangzhou Bio-gene Technology C…Phase 1

CDH17 CAR-T (CDH17 CAR-T)

Biliary Tract Cancer; Colorectal Carcinoma · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 5상태 RECRUITING

ADCBiologicstaleGV20 TherapeuticsPhase 2

GV20-0251 (GV20-0251)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 5상태 RECRUITING

ADCBiologicstaleHansoh BioMedical R&D CompanyPhase 1

HS-20089 (HS-20089)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 5상태 RECRUITING

CGTBiologicstaleEssen BiotechPhase 1

Mesothelin-directed CAR-T cells (Mesothelin-directed CAR-T cells)

Solid Tumor, Adult · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 5상태 ACTIVE

CGTBiologicstaleBristol-Myers SquibbPhase 1

NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL (NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL)

Unspecified Adult Solid Tumor, Protocol Specific · Unspecified Adult Solid Tumor, Protocol

#UnspecifiedAdultSolidTumorProtoc#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 5상태 ACTIVE

ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6002 (SYS6002)

Advanced Urothelial Carcinoma · Advanced Urothelial Carcinoma

#AdvancedUrothelialCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 5상태 RECRUITING

AntibodystaleXencor, Inc.Phase 2

Vudalimab (Vudalimab)

Ovarian Cancer; Clear Cell Carcinoma · Castration-Sensitive Prostate Carcinoma

#Castration-SensitiveProstateCarc#Antibody#Phase2#항체#면역항체+4

임상시험 5상태 DISCONTINUED

ADCBiologicstaleHoffmann-La RochePhase 2

ZN-A-1041 (ZN-A-1041)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 5상태 RECRUITING

ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

sigvotatug vedotin (sigvotatug vedotin)

Carcinoma, Non-Small Cell Lung; Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small Cell Lung

#CarcinomaNon-SmallCellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4

임상시험 5상태 RECRUITING

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

5-hydroxytryptamine subtype 3 receptor antagonist (5-hydroxytryptamine subtype 3 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 4상태 RECRUITING

ADCBiologicstaleHoffmann-La RochePhase 2

Belvarafenib (Belvarafenib)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 4상태 RECRUITING

ADCBiologicstaleDay One Biopharmaceuticals, Inc.Phase 1

DAY301 (DAY301)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

임상시험 4상태 RECRUITING

ADCBiologicstaleDualityBio Inc.Phase 2

DB-1311/BNT324 (DB-1311/BNT324)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 4상태 RECRUITING

AntibodystaleEisai Inc.Phase 2

Farletuzumab ecteribulin (Farletuzumab ecteribulin)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+2

효능 ORR 20%임상시험 4상태 RECRUITING

AntibodystaleEli Lilly and CompanyPhase 2

Icrucumab (Icrucumab)

Colon Cancer; Rectal Cancer · Carcinoma of Urinary Tract

#CarcinomaofUrinaryTract#Antibody#Phase2#항체#면역항체+4

효능 ORR 28.8%임상시험 4상태 ACTIVE

13 / 46 페이지

← 이전 다음 →

갱신 기록 없음 · 14일 주기 · 방문 0 / 568